Sarah Mougalian Selected Research

ORALIT (ORS)

11/2018

Breast cancer histopathology is predictive of low-risk Oncotype Dx recurrence score.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sarah Mougalian Research Topics

Disease

11	Breast Neoplasms (Breast Cancer) 01/2021 - 06/2015
6	Neoplasms (Cancer) 06/2018 - 06/2015
2	Neoplasm Metastasis (Metastasis) 11/2018 - 06/2015
2	Pathologic Complete Response 06/2018 - 12/2015
1	Carcinoma (Carcinomatosis) 11/2018
1	Ductal Carcinoma 11/2018

Drug/Important Bio-Agent (IBA)

4	Estrogen ReceptorsIBA 12/2017 - 06/2015
2	Hormones (Hormone)IBA 01/2021 - 10/2017
2	Trastuzumab (Herceptin)FDA Link 11/2018 - 06/2018
2	Paclitaxel (Taxol)FDA LinkGeneric 06/2018 - 08/2017
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 06/2018 - 08/2017
1	Everolimus FDA Link 01/2021
1	exemestane (Aromasin)FDA Link 01/2021
1	ORALIT (ORS)IBA 11/2018
1	N-acetyltalosaminuronic acid (NAT)IBA 11/2018
1	Fluorouracil (Carac)FDA LinkGeneric 06/2018
1	Epirubicin (Ellence)FDA LinkGeneric 06/2018
1	pertuzumabIBA 06/2018
1	AnthracyclinesIBA 06/2018
1	taxaneIBA 06/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2017
1	Docetaxel (Taxotere)FDA Link 08/2017
1	Pharmaceutical PreparationsIBA 04/2016
1	human ERBB2 proteinIBA 12/2015
1	Progesterone Receptors (Progesterone Receptor)IBA 12/2015
1	2- benzylidene- 3- (cyclohexylamino)- 2,3- dihydro- 1H- inden- 1- oneIBA 12/2015

Therapy/Procedure

4	Therapeutics 01/2021 - 12/2015
4	Neoadjuvant Therapy 11/2018 - 06/2015
3	Adjuvant Chemotherapy 12/2017 - 06/2015
2	Segmental Mastectomy (Lumpectomy) 01/2017 - 01/2016
1	Radiotherapy 01/2017
1	Lymph Node Excision (Lymph Node Dissection) 01/2016
1	Drug Therapy (Chemotherapy) 12/2015